STP206
Biological
Leadiant Biosciences, Inc.
Total Payments
$420,479
Transactions
94
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $21,582 | 6 | 0 |
| 2018 | $225,934 | 41 | 5 |
| 2017 | $172,964 | 47 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $403,691 | 89 | 96.0% |
| Consulting Fee | $16,788 | 5 | 4.0% |
Payments by Type
Research
$403,691
89 transactions
General
$16,788
5 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Phase Ib/IIa Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates | Leadiant Biosciences, Inc. | $230,728 | 0 |
| A PHASE 1B/IIA RANDOMIZED, PLACEBO CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ONCE DAILY DOSING OF STP206 IN PREMATURE VERY LOW BIRTH WEIGHT AND EXTREMELY LOW BIRTH WEIGHT NEONATES | Leadiant Biosciences, Inc. | $172,964 | 1 |
Top Doctors Receiving Payments for STP206
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Springfield, MA | $400,391 | 88 |
| , MD | Neonatal-Perinatal Medicine | Wilmington, NC | $5,400 | 1 |
| Danny Benjamin | — | Durham, NC | $4,794 | 1 |
| , MD | Neonatal-Perinatal Medicine | Durham, NC | $4,794 | 1 |
| , M.D | Pediatrics | Tampa, FL | $3,300 | 1 |
| , M.D | Neonatal-Perinatal Medicine | Newton, MA | $900.00 | 1 |
| , MD | Neonatal-Perinatal Medicine | Salt Lake City, UT | $900.00 | 1 |
Ad
Manufacturing Companies
- Leadiant Biosciences, Inc. $420,479
Product Information
- Type Biological
- Total Payments $420,479
- Total Doctors 6
- Transactions 94
About STP206
STP206 is a biological associated with $420,479 in payments to 6 healthcare providers, recorded across 94 transactions in the CMS Open Payments database. The primary manufacturer is Leadiant Biosciences, Inc..
Payment data is available from 2017 to 2019. In 2019, $21,582 was paid across 6 transactions to 0 doctors.
The most common payment nature for STP206 is "Unspecified" ($403,691, 96.0% of total).
STP206 is associated with 2 research studies, including "A Phase Ib/IIa Randomized, Placebo Controlled Study of the Safety and Efficacy of Once Daily Dosing of STP206 in Premature Very Low Birth Weight and Extremely Low Birth Weight Neonates" ($230,728).